HACARUS DD

Drug Discovery Support AI platform

Enabling a smarter approach to drug discovery

Our AI platform supports drug discovery researchers by streamlining image analysis. HACARUS's original AI technology builds highly interpretable AI without using big data. By combining the knowledge of drug discovery researchers with AI, we will contribute to the realization of a more efficient and rapid drug discovery process.

Enabling a smarter approach to drug discovery

Our AI platform supports drug discovery researchers by streamlining image analysis. HACARUS's original AI technology builds highly interpretable AI without using big data. By combining the knowledge of drug discovery researchers with AI, we will contribute to the realization of a more efficient and rapid drug discovery process.

Phenotypic screening support AI


Faster and clearer AI that supports phenotypic screening

Cell image analysis is essential for phenotypic screening. HACARUS DD, which utilizes sparse modeling technology, solves problems that could not be solved by conventional analysis methods.



Conventional AI Approach


It takes time to evaluate and determine the effects of new candidate drugs because it is necessary to create different AI for each drug.


I don't know what features of the image influenced the determination of reaction

HACARUS Approach


One AI model trained from images of a normal control group can be used for multiple candidate drugs. Evaluation and judgment time is shorter than the conventional approach.


By presenting changes in image characteristics due to experiments, we can obtain hints on the mechanism of action of drugs.



Engagement Model

Information gathering


From Customer

Inquiry / Area of interest


HACARUS & Customer

Requirement Capturing

Assessment


From Customer

Transfer of sample images


HACARUS

AI assessment


HACARUS & Customer

Assessment result report / PoC proposal

Creating AI for customers


HACARUS

Creating AI using customer data and HACARUS engine
Performance evaluation and tuning


From Customer

Confirmation of evaluation results

Integration


HACARUS

Incorporating the AI created in the previous step
into the HACARUS DD platform


From Customer

Usage of the HACARUS DD Platform




Inquiry & Request for Materials

R&D Activities in the field of Drug Discovery

We aim to make further contributions to drug discovery research based on our knowledge of AI development.


                               
Target Discovery​ Drug Discovery Preclinical
Oncology

Joint research aimed at elucidating the mechanism of cancer cell metabolism (with Kyoto University / Professor Ito)

Joint research to improve the efficiency of anti-cancer drug discovery (with Keio University / Professor Saya)
Central Nervous System

AI drug discovery research aimed at developing treatments for Alzheimer's disease and Parkinson's disease (with University of Tokyo / Professor Tomita)


Case StudyCase Studies

Subscribe to our newsletter

Click here to sign up